Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adel Alharf

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Epidemiology|May 28, 2024
Hospitalization Endpoint in Clinical Trials of Outpatient Settings: using Anti-SARS-COV-2 Therapy as an ExampleAlhanouf Yousef Alnafisah, Ahmed Fawaz Alkhalidi, Hanin Aljohani, et al.
Therapeutic Innovation & Regulatory Science|December 26, 2024
Descriptive Analysis of Good Clinical Practice Inspection Findings from the Saudi Food and Drug AuthorityOmaima O Arab, Mohammed Aldayan, Khalid Almowaizri, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|March 21, 2018
Saudi Vigilance Program: Challenges and lessons learnedAdel Alharf, Nasser Alqahtani, Ghazi Saeed, et al.
European Journal of Clinical Pharmacology|July 23, 2020
Blood pressure-lowering activity of statins: a systematic literature review and meta-analysis of placebo-randomized controlled trialsJahad Alghamdi, Abdulziz Alqadi, Adel Alharf, et al.
Bulletin of the World Health Organization|August 4, 2022
National medicines policy development, Saudi ArabiaKhalid Almoteiry, Adel Alharf, Bandar Al Hammad, et al.
The Pharmacogenomics Journal|February 5, 2023
Targeted next-generation sequencing of genes involved in Warfarin Pharmacodynamics and pharmacokinetics pathways using the Saudi Warfarin Pharmacogenetic study (SWAP)Maha Al Ammari, Bader Almuzzaini, Khalid Al Sulaiman, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|April 5, 2024
The bioequivalence study design recommendations for immediate-release solid oral dosage forms in the international pharmaceutical regulators programme participating regulators and organisations: differences and commonalitiesEduardo Agostinho Freitas Fernandes, Joy van Oudtshoorn, Andrew Tam, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|November 5, 2025
A survey of regulatory recommendations for waivers of <i>in vivo</i> bioequivalence studies of generic products for certain dosage forms by participating regulators and organisations of the International Pharmaceutical Regulators Programme. Part 2Alfredo García-Arieta, Andrew Tam, Florencia Tiseyra, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Epidemiology|May 28, 2024
Hospitalization Endpoint in Clinical Trials of Outpatient Settings: using Anti-SARS-COV-2 Therapy as an ExampleAlhanouf Yousef Alnafisah, Ahmed Fawaz Alkhalidi, Hanin Aljohani, et al.
Therapeutic Innovation & Regulatory Science|December 26, 2024
Descriptive Analysis of Good Clinical Practice Inspection Findings from the Saudi Food and Drug AuthorityOmaima O Arab, Mohammed Aldayan, Khalid Almowaizri, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|March 21, 2018
Saudi Vigilance Program: Challenges and lessons learnedAdel Alharf, Nasser Alqahtani, Ghazi Saeed, et al.
European Journal of Clinical Pharmacology|July 23, 2020
Blood pressure-lowering activity of statins: a systematic literature review and meta-analysis of placebo-randomized controlled trialsJahad Alghamdi, Abdulziz Alqadi, Adel Alharf, et al.
Bulletin of the World Health Organization|August 4, 2022
National medicines policy development, Saudi ArabiaKhalid Almoteiry, Adel Alharf, Bandar Al Hammad, et al.
The Pharmacogenomics Journal|February 5, 2023
Targeted next-generation sequencing of genes involved in Warfarin Pharmacodynamics and pharmacokinetics pathways using the Saudi Warfarin Pharmacogenetic study (SWAP)Maha Al Ammari, Bader Almuzzaini, Khalid Al Sulaiman, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|April 5, 2024
The bioequivalence study design recommendations for immediate-release solid oral dosage forms in the international pharmaceutical regulators programme participating regulators and organisations: differences and commonalitiesEduardo Agostinho Freitas Fernandes, Joy van Oudtshoorn, Andrew Tam, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|November 5, 2025
A survey of regulatory recommendations for waivers of <i>in vivo</i> bioequivalence studies of generic products for certain dosage forms by participating regulators and organisations of the International Pharmaceutical Regulators Programme. Part 2Alfredo García-Arieta, Andrew Tam, Florencia Tiseyra, et al.
Pageof 1